RAPP Operating Cash Flow (Statement)
Rapport Therapeutics Inc · Operating Cash Flow (Statement)
RAPP Operating Cash Flow (Statement)
Latest reported-$96.68Mperiod ending
RAPP TTM Cash from Operations (-$27.18M → -$96.68M)
TTM operating cash flow (statement)
High-resolution chart · PNG
RAPP operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -96,682,000 | |
| -80,297,000 | |
| -87,473,000 | |
| -77,218,000 | |
| -76,168,000 | |
| -67,450,000 | |
| -64,828,000 | |
| -60,739,000 | |
| -49,748,000 | |
| -39,995,000 | |
| -27,181,000 |